{"id":452402,"date":"2019-11-27T10:02:01","date_gmt":"2019-11-27T10:02:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=452402"},"modified":"2019-11-27T10:02:01","modified_gmt":"2019-11-27T10:02:01","slug":"bric-diabetes-care-devices-market-explore-growth-of-482-billion-by-2026-key-players-johnson-johnson-ypsomed-ag-bayer-ag-f-hoffmannla-roche-ltd","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/bric-diabetes-care-devices-market-explore-growth-of-482-billion-by-2026-key-players-johnson-johnson-ypsomed-ag-bayer-ag-f-hoffmannla-roche-ltd_452402.html","title":{"rendered":"BRIC Diabetes Care Devices Market Explore Growth Of $4.82 Billion By 2026: Key Players Johnson & Johnson, Ypsomed AG, Bayer AG, F. Hoffmann-La Roche Ltd"},"content":{"rendered":"
\"BRIC<\/a><\/p>\n
\n
Grand View Research, Inc. – Market Research And Consulting.<\/div>\n<\/div>\n<\/div>\n
According to report published by Grand View Research, The BRIC diabetes care devices market size was valued at USD 3.22 billion in 2018 and is expected to expand at a CAGR of 5.28% during the forecast period.<\/div>\n

The BRIC diabetes care devices market<\/a> size is projected to reach USD 4.82 million by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a 5.28% CAGR over the forecast period. The market in BRIC nations is primarily driven by the increasing prevalence of diabetes, especially among geriatric and obese population. Increasing collaboration and funding support to research is further augmenting the growth. The factors responsible for the increasing incidence of glucose impairment are the increasing alcohol and tobacco consumption, lack of physical activity, and obesity. However, increasing prices of advanced devices and presence of cost-effective alternative treatment may restrict the market growth.<\/p>\n

BRIC nations are also witnessing large untapped opportunities with favorable government initiatives focused on disease awareness. According to the World Health Organization (WHO), more than 50% Indian population with diabetes remains undiagnosed. Many government initiatives and approval from the Food and Drug Administration (FDA) for advanced diabetes care devices are also propelling the growth. For instance, in 2019, the Research Trust of Diabetes India launched its 1000 days Initiative to control diabetes in the country. This initiative will bring together diabetologists across India to provide recommendations and clinical guidelines. Furthermore, technological advancements coupled with collaboration among key market players is also propelling the market growth. For instance, in September 2019, Abbott and Sanofi collaborated to work on tools that integrate Sanofi’s insulin dosing information with Abbott’s FreeStyle Libre technology.<\/p>\n

Browse Details of Report, Please Visit @ https:\/\/www.grandviewresearch.com\/industry-analysis\/bric-diabetes-care-devices-market<\/a><\/strong><\/p>\n

\"Brazil<\/p>\n

Key Takeaways from the report:<\/strong><\/p>\n